Oak Street Health, Inc.
OSH was delisted on the 1st of May, 2023.
2 hedge funds and large institutions have $8.5M invested in Oak Street Health, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 269 closing their positions.
99% less funds holding
Funds holding: 272 → 2 (-270)
100% less capital invested
Capital invested by funds: $8.38B → $8.5M (-$8.37B)
100% less funds holding in top 10
Funds holding in top 10: 26 → 0 (-26)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 269
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
General Atlantic
New York
|
-$2.37B |
| 2 |
NP
Newlight Partners
New York
|
-$1.26B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$471M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$362M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$193M |
OSH Hedge Fund Activity: Q2 2023 in Review
2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q2 2023, worth a combined $8.5M — down 100% from $8.38B a quarter earlier.
Sellers outnumbered buyers: 269 funds closed out of OSH and 0 opened new positions — a net loss of 269 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was General Atlantic, exiting entirely with an estimated $2.37B sold.
- 2 institutional investors held Oak Street Health, Inc. (OSH) as of Q2 2023, down from 272 in Q1 2023.
- Funds reported $8.5M of Oak Street Health, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Oak Street Health, Inc. positions in Q2 2023 and 269 closed out, a net change of -269 holders.
- The largest Oak Street Health, Inc. seller in Q2 2023 was General Atlantic, an estimated $2.37B sold.
Based on aggregated 13F filings for Q2 2023.